Cancer – Ho Hum

Your smart phone reminds you – time for the annual test. You buy a capsule of nanoparticles – each one graphene with a tiny magnetic core, biodegradable and harmless, so available over-the-counter. If you’ve lost it since last year, you buy the corresponding wrist band to wear after swallowing the capsule.

Inside your body, the nanoparticles spread out. If they encounter some cancerous cells, they bind to them and mobilize some into your blood stream. Passing by the wrist band, they signal a positive result.

“Well, shoot,” you say. “I’ve got cancer. Better make an appointment – hmmm. I’m meeting friends for lunch on Tuesday. Let’s make it Wednesday.”

You don’t even need to see a doctor. Technicians slide you into a radio-frequency unit, maybe after another nanoparticle dose. Radio waves kill every cancer cell in your body – solid tumor, free-floating metastasized, it doesn’t matter – without damage to healthy cells.

“Better repeat the diagnostic test in a month,” the technician warns.

Yeah, yeah… You tap the new date into your phone and go merrily on your way.

Science fiction? Distant future?

Maybe not.

“This May, [Dr. Steven A. Curley, oncologist] filed protocols with the Italian Ministry of Health to test the radio wave machine on humans diagnosed with pancreatic and liver cancer. Pending approval in the fall, human clinical trials will begin in the spring of next year in Naples, Italy.”

The initial studies are aimed at proving the treatment is safe for humans. Success will mean trials to find out how effective it is.

Where did this idea come from? John Kanzius was a retired radio engineer, amateur radio operator, and dying of leukemia. Sick from chemotherapy, he became a citizen scientist, studied the latest cancer research, developed a radiofrequency-based concept to kill cancer cells without invasive surgery or chemotherapy, demonstrated the technique on hot dogs in his basement shop, dogged oncologists until he teamed up with Dr. Curley, and – well – read the story at (Note how different it is from inventors of perpetual motion machines or pills to turn water into gasoline, who claim persecution.)

Professional researchers tackled Kanzius’ inspiration.

Kanzius succumbed to his cancer in 2009, but Curley and his team (Curley has 20 researchers with expertise in nanomaterials, radiofrequency, immune function and drug delivery functions working in his lab at the Dan L. Duncan Cancer Center at Baylor College of Medicine in Houston, Texas) have carried on and now – maybe science fiction will become science fact.

If you’ve ever read that “they” don’t want to cure your illness, just get rich off pushing dreadful medical treatments, or “they” won’t look at ideas from outside their own lab, here’s the happy counterproof – and not just one odd-ball researcher but many.

Perhaps in the foreseeable future, the cancer industry will disappear and a diagnosis of cancer will be more like an ingrown toenail than a death sentence.

In the meantime, I applaud citizen-scientists and open-minded professionals everywhere.

Both RF_alum and I are cancer survivors, and both past employees of Rocky Flats nuclear weapons plant (where cancer was cussed and discussed, as noted in the brief chapter on cancer in RF_alum’s excellent book An Insiders View of Rocky Flats.) So cancer news tends to catch our eyes.

BTW – Keep the champagne corked for now: “Curley is hopeful, but more cautious than Kanzius was, pointing out: ‘A whole bunch of us have been able to cure cancer in animals. You go to humans, and sometimes there are opposite results,’ he says. ‘You never know’.” And “I don’t tell patients they are cured until eight, nine, 10 years down road.”

Here’s another twist – Kanzius Cancer Research, a registered, 501(c)3 nonprofit organization, has completed its mission and ceased operations as of June 30, 2014. It granted its remaining assets to three, newly created funds to facilitate Phase II human clinical trials right here in the USA. No endless fundraising here!

Leave a Reply

Your email address will not be published. Required fields are marked *